CycloLab picks up the gauntlet to fight coronavirus
The novel coronavirus SARS-CoV-2 is affecting 65 countries and territories around the world with almost 90,000 reported cases and almost
Category: Uncategorized
Gilead Sciences Initiates Two Phase 3 Studies of Investigational SBECD-enabled Antiviral Remdesivir for the Treatment of COVID-19
Gilead Sciences, Inc. yesterday announced the initiation of two Phase 3 clinical studies to evaluate the safety and efficacy of
iFLUX launches cyclodextrin-based PFAS cartridge to monitor mobility of PFAS groundwater plumes
Much has already been written about PFAS. But when it comes to the behavior of PFAS in groundwater, there’s less
Bacteria, viruses, coronavirus, fear or not?
Bacteria are single-celled prokaryotic microorganisms, that means they do not have a true nucleus, mitochondria, or any other membrane-bound organelle
Cyclo Therapeutics Presents Clinical Trial Data on Niemann-Pick Type C Disease
Cyclo Therapeutics, Inc. a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C (NPC)
Cyclodextrin-based nanozymes
Nanozymes are nanomaterials with enzyme-like properties. These artificial enzymes have emerged more robust than the natural enzymes and find applications
Fraud companies infiltrating cyclodextrin business
I would like to draw your attention to a very recent desperate approach for taking advantage of one’s naivety and